|
Issue |
Title |
|
Vol 13, No 1 (2020) |
Prospects for the use of chondroitin sulfate and glucosamine sulfate with osteoarthritis associated with pathology of the kidneys and urinary system |
Abstract
PDF (Rus)
|
I. Yu. Torshin, A. М. Lila, O. A. Limanova, O. A. Gromova |
|
Vol 13, No 1 (2020) |
Real-time RT-PCR diagnostics of virus causing COVID-19 |
Abstract
PDF (Rus)
|
E. V. Goncharova, A. E. Donnikov, V. V. Kadochnikova, S. A. Morozova, M. N. Boldyreva, I. S. Galkina, D. V. Blinov |
|
Vol 13, No 1 (2020) |
COVID-19 in Moscow: prognoses and scenarios |
Abstract
PDF (Rus)
|
M. V. Tamm |
|
Vol 13, No 1 (2020) |
Pharmacoeconomic efficacy of atesolizumab compared with other PD-1 inhibitors in patients with advanced non-small cell lung cancer after chemotherapy |
Abstract
PDF (Rus)
|
S. K. Zyryanov, I. N. Diyakov |
|
Vol 13, No 1 (2020) |
The pharmacoeconomic efficacy of chemotherapy for malignant neoplasms of the bronchus and lung |
Abstract
PDF (Rus)
|
S. K. Yarovoy, I. B. Shikina |
|
Vol 13, No 1 (2020) |
Health technology assessment in obstetrics: advantage of tailored conservative strategy vs surgical therapies of monochorionic twin complicated by TRAP-sequence |
Abstract
PDF (Rus)
|
V. I. Tsibizova, I. E. Govorov, I. I. Averkin, N. M. Khamani, D. V. Blinov |
|
Vol 12, No 3 (2019) |
Availability and Pharmacoeconomics of Insulin Therapy in Countries with the Largest Number of Diabetics |
Abstract
PDF (Eng)
|
S. V. Ponomarenko |
|
Vol 12, No 3 (2019) |
Comorbidity in elderly patients with atrial fibrillation affects the “cost of illness” |
Abstract
PDF (Rus)
|
S. V. Malchikova , N. S. Maksimchuk-Kolobova, M. V. Kazakovtseva |
|
Vol 12, No 3 (2019) |
Pharmacoepidemiological analysis of antimicrobial therapy for burn injury in the hospital settings |
Abstract
PDF (Rus)
|
O. V. Zhukova, E. S. Nekaeva, E. S. Khoroshavina, E. A. Kozlova, Yu. A. Dudukina, I. Yu. Arefyev |
|
Vol 12, No 3 (2019) |
Clinical and economic analysis as an instrument for harmonizing import substitution in the preferential segment of medicinal support |
Abstract
PDF (Rus)
|
E. V. Eliseeva , E. S. Maneeva , R. K. Goncharova , A. V. Kropotov |
|
Vol 12, No 3 (2019) |
Overview of the existing opportunities and limitations of the state guarantees program for provision of free medical care to citizens |
Abstract
PDF (Rus)
|
D. V. Fedyaev , R. V. Gostishchev , V. A. Lemeshko , O. I. Ivakhnenko |
|
Vol 12, No 3 (2019) |
Approaches to assessing the demand for medical personnel in the Russian Federation |
Abstract
PDF (Rus)
|
S. N. Tishkina , T. G. Alkhasov , D. V. Lukyantseva , T. P. Bezdenezhnykh |
|
Vol 12, No 1 (2019) |
Prevalence survey of musculoskeletal and connective tissue disorders in the Russian Federation |
Abstract
PDF (Rus)
|
T. A. Oleynikova, D. N. Pozhidaeva, A. Yu. Oreshko |
|
Vol 12, No 1 (2019) |
Economic consequences of healthcare optimization for IBD patients in the Republic of Tatarstan |
Abstract
PDF (Rus)
|
T. P. Bezdenezhnykh, D. V. Fedyaev, G. R. Khachatryan, G. G. Arutyunov, K. V. Gerasimova |
|
Vol 12, No 1 (2019) |
Effective search for potentially innovative scientific results in medicine |
Abstract
PDF (Rus)
|
M. B. Khrustalev, A. A. Maksimova |
|
Vol 12, No 1 (2019) |
The use of the level of evidence and grade of recommendations scales in developing clinical guidelines in the Russian Federation |
Abstract
PDF (Rus)
|
N. I. Zhuravleva, L. C. Shubina, O. A. Sukhorukikh |
|
Vol 12, No 1 (2019) |
Efficacy of photodynamic therapy in treatment of adult patients with skin cancer |
Abstract
PDF (Rus)
|
O. V. Kirsanova |
|
Vol 11, No 4 (2018) |
Direct medical costs of using enzalutamide or abiraterone in chemotherapy-naïve patients with metastatic castration resistant prostate cancer |
Abstract
PDF (Rus)
|
N. A. Avxentyev, A. S. Makarov, M. Yu. Frolov |
|
Vol 11, No 4 (2018) |
Costs of pharmacotherapy in pediatric patients with community-acquired pneumonia: mathematical and statistical analysis |
Abstract
PDF (Rus)
|
I. A. Narkevich, O. D. Nemyatyh, D. D. Siukaeva, I. V. Pavlushkov, D. O. Ivanov, Ya. V. Panyutina |
|
Vol 11, No 4 (2018) |
Treatment of patients with malignant lymphoproliferative diseases in the Russian Federation: analysis of the data from 75 regions |
Abstract
PDF (Rus)
|
G. R. Hachatryan, T. S. Teptsova, V. A. Lemeshko, N. Z. Musina |
|
Vol 11, No 4 (2018) |
Modeling the effect of enzyme replacement therapy on life-threatening complications in patients with Fabry disease |
Abstract
PDF (Rus)
|
V. I. Ignatyeva, S. V. Moiseev, N. M. Bulanov, E. A. Karovajkina, A S. Moiseev |
|
Vol 11, No 3 (2018) |
The concept of multi-criteria analysis of decision-making in the current system of health technology assessment in Russia |
Abstract
PDF (Rus)
|
V. V. Omelyanovsky, V. K. Fedyaeva, N. Z. Musina |
|
Vol 11, No 3 (2018) |
Use of medications in children hospitalized with community-acquired pneumonia |
Abstract
PDF (Rus)
|
D. D. Siukaeva, I. A. Narkevich, V. N. Timchenko, O. D. Nemyatyh, N. A. Maslova |
|
Vol 11, No 3 (2018) |
Determination of a willingness-to-pay threshold and decision-making in financing the healthcare technologies |
Abstract
PDF (Rus)
|
T. S. Teptsova, T. P. Bezdenezhnyh, V. K. Fedyaeva, N. Z Musina, G. R. Hachatryan, V. V. Tarasov |
|
Vol 11, No 3 (2018) |
Pharmacoeconomic analysis of using belimumab for the treatment of systemic lupus erythematosus |
Abstract
PDF (Rus)
|
A. G. Tolkushin, N. L. Pogudina |
|
Vol 11, No 3 (2018) |
What is the role of antineoplastic drug safety in reimbursement decision making? |
Abstract
PDF (Rus)
|
A. S. Kolbin, A. A. Kurylev |
|
Vol 11, No 2 (2018) |
Economic evaluation of postoperative hypofractionated radiation therapy in patients with breast cancer |
Abstract
PDF (Rus)
|
G. V. Afonin, Yu. A. Ragulin, M. V. Avxentyeva, I. A. Gulidov, S. A. Ivanov, A. D. Kaprin |
|
Vol 11, No 2 (2018) |
Pharmacoeconomic analysis of using typical and atypical antipsychotics in schizophrenia |
Abstract
PDF (Rus)
|
I. A. Vilyum, B. V. Andreev, M. A. Proskurin, Yu. E. Balykina |
|
Vol 11, No 2 (2018) |
Pharmacoeconomic analysis of treatment with nilotinib as the second line therapy in patients with chronic myeloid leukemia |
Abstract
PDF (Rus)
|
N. A. Avxentyev, M. Yu. Frolov, A. S. Makarov |
|
Vol 11, No 2 (2018) |
Clinical and economic efficiency of the loop ileostomy closure by various methods |
Abstract
PDF (Rus)
|
A. V. Veselov, S. I. Achkasov, O. I. Sushkov, A. I. Moskalev, I. S. Lantsov |
|
Vol 11, No 2 (2018) |
Regional adaptation of the federal model of reimbursement for medical assistance based on clinical statistical groups: hospitalization of patients in need of genetically enginered biological preparations |
Abstract
PDF (Rus)
|
M. V. Sura, T. N. Ignatova, N. S. Rudneva, Yu. N. Sukhanova, N. G. Ulyanova, A. S. Khudyaev, V. A. Shelyakin, D. V. Scherbakov |
|
Vol 11, No 2 (2018) |
Implementation of the Federal Law «On Protection of Consumer Rights» in the provision of paid medical services: recommendations on signing the contract |
Abstract
PDF (Rus)
|
M. A. Amkhadova, E. V. Batler, D. G. Ilyuhin, I. A. Petrova |
|
Vol 11, No 1 (2018) |
CYP2D6 genotyping in the daily routine of a psychiatric hospital – pharmacoeconomic evaluation |
Abstract
PDF (Rus)
|
A. A. Kurylev, B. V. Andreev, A. S. Kolbin, O. V. Limankin |
|
Vol 11, No 1 (2018) |
Modeling microbial drug-resistance: from mathematics to pharmacoeconomics |
Abstract
PDF (Rus)
|
Yu. M. Gomon, M. A. Arepyeva, Yu. E. Balykina, A. S. Kolbin, A. A. Kurylev, M. A. Proskurin, S. V. Sidorenko |
|
Vol 11, No 1 (2018) |
Antimicrobial therapy of community-acquired pneumonia in a hospital setting (clinical and economic aspects) |
Abstract
PDF (Rus)
|
O. V. Zhukova, O. V. Ruina, M. V. Khazov, S. V. Romanov |
|
Vol 11, No 1 (2018) |
Pharmacoeconomic assessment of antipsychotic treatment in outpatients with schizophrenia |
Abstract
PDF (Rus)
|
I. A. Vilyum, B. V. Andreev, M. A. Proskurin, Yu. E. Balykina |
|
Vol 10, No 4 (2017) |
INTERNATIONAL APPROACHES TO THE GOVERNMENT PRICE CONTROL OVER GENERICS AND BIOSIMILARS: A REVIEW |
Abstract
PDF (Rus)
|
D. G. Tolkacheva, A. V. Torgov, A. S. Margazova |
|
Vol 10, No 4 (2017) |
PHARMACOECONOMIC JUSTIFICATION OF A WIDER USE OF PREVENTIVE HEMOPHILIA THERAPY IN THE RUSSIAN FEDERATION |
Abstract
PDF (Rus)
|
M. Yu. Frolov, V. A. Rogov |
|
Vol 10, No 4 (2017) |
INTERNATIONAL APPROACHES TO THE GOVERNMENT PRICE CONTROL OVER GENERICS AND BIOSIMILARS: A REVIEW |
Abstract
PDF (Rus)
|
D. G. Tolkacheva, A. V. Torgov, A. S. Margazova |
|
Vol 10, No 4 (2017) |
IMPROVEMENT OF PRICE REGULATION FOR INNOVATIVE MEDICINES COVERED BY THE NATIONAL BUDGET |
Abstract
PDF (Rus)
|
V. A. Lemeshko, N. Z. Musina, V. K. Fedyaeva |
|
Vol 10, No 4 (2017) |
SOURCES OF BIAS IN SELF-ASSESSED HEALTH |
Abstract
PDF (Rus)
|
C. J. Gerry, V. M. Baydin |
|
Vol 10, No 3 (2017) |
The strategies of drug supply for patients with chronic hepatitis C |
Abstract
PDF (Rus)
|
E. V. Kornilova, A. D. Ermolaeva, M. G. Rusanova, D. A. Andreev, M. V. Davydovskaya, T. N. Ermolaeva, A. g Pokatilo, K. I. Polyakova, V. A. Dubovtseva, K. А. Kokushkin, A. V. Devyatkin |
|
Vol 10, No 3 (2017) |
Comparative pharmaco-economic analysis of using enzalutamide, abiraterone and cabazitaxel in post-docetaxel castration-resistant prostate cancer patients |
Abstract
PDF (Rus)
|
N. K. Mazina, P. V. Mazin |
|
Vol 10, No 3 (2017) |
Evaluation of economic damage from multiple sclerosis in the city of Ufa, Russia |
Abstract
PDF (Rus)
|
E. V. Ivanova, K. Z. Bachtiyarova |
|
Vol 10, No 3 (2017) |
ABC-analysis of pharmacotherapy in children hospitalized with bronchial asthma exacerbations |
Abstract
PDF (Rus)
|
O. V. Zhukova, S. V. Kononova |
|
Vol 10, No 3 (2017) |
Initiation and intensification of insulin therapy in patients with type 2 diabetes mellitus: a budget impact analysis |
Abstract
PDF (Rus)
|
E. V. Biryukova, V. I. Ignat’eva |
|
Vol 10, No 2 (2017) |
COMPARATIVE COST-MINIMIZATION AND BUDGET-IMPACT ANALYSIS OF FIXED-DOSE INHALED CORTICOSTEROID / LONG-ACTING BETAAGONIST COMBINATIONS IN THE TREATMENT OF ASTHMA |
Abstract
PDF (Rus)
|
N. L. Pogudina, E. G. Kosolapov, F. S. Kochenkov, A. V. Karaulov, N. L. Bondarenko, D. V. Blinov |
|
Vol 10, No 2 (2017) |
COST-MINIMIZATION OF VILANTEROL / UMECLIDINIUM VERSUS OLODATEROL / TIOTROPIUM IN THE BASIC THERAPY OF SEVERE AND VERY SEVERE COPD |
Abstract
PDF (Rus)
|
E. G. Kosolapov, F. S. Kochenkov, N. L. Pogudina, D. V. Blinov, N. L. Bondarenko, A. V. Karaulov |
|
Vol 10, No 2 (2017) |
COST-EFFECTIVENESS OF VILANEROL / UMECLIDINIUM VERSUS TIOTROPIUM IN SEVERE AND VERY SEVERE COPD |
Abstract
PDF (Rus)
|
E. G. Kosolapov, F. S. Kochenkov, N. L. Pogudina, D. V. Blinov |
|
Vol 10, No 2 (2017) |
CLINICAL AND ECONOMIC EVALUATION OF CHRONIC DISEASE TREATMENT: A DISCREPANCY BETWEEN THE TRADITIONAL PHARMACOECONOMIC AND SOCIO-ECONOMIC ANALYSES |
Abstract
PDF (Rus)
|
O. V. Zhukova, S. V. Kononova |
|
1 - 50 of 111 Items |
1 2 3 > >>
|